Clinical Research Directory

Inclusion Criteria: 1. Patients aged 18 year and over 2. Tertiary MDT diagnosis of FILD with \>10% fibrosis on CT chest as determined by the investigator. Underlying diagnoses to include but not limited to: idiopathic pulmonary fibrosis (IPF), non-specific interstitial pneumonitis (NSIP), chronic hypersensitivity pneumonitis (CHP), connective tissue disease-related interstitial lung disease (CTD-ILD), fibrotic organising pneumonia (FOP) and pulmonary sarcoidosis. 3. Able to provide informed written consent Exclusion Criteria: 1. The use of or any indication for long-term oxygen therapy (LTOT) 2. Known moderate or severe obstructive sleep apnoea with an apnoea/hypopnoea index (AHI) or oxygen desaturation index (ODI) over 15 events per hour 3. Radiological predominance of emphysema compared with fibrosis on CT chest 4. Inability to complete all health status questionnaires as set out in this protocol, with appropriate support 5. A confirmed diagnosis of pulmonary hypertension 6. Significant cardiovascular comorbidity including severe, uncontrolled hypertension, uncontrolled arrhythmia, recent acute coronary syndrome within 30 days prior to study enrolment, that could mean exercise testing poses a risk to patient health, in the opinion of the investigator 7. Musculoskeletal comorbidity that will preclude the participant's ability to reliably complete the complete 6-minute walk test (6MWT) 8. Participation in another research project which may confound this study's research findings